Developing and Validating Health Education Module for Prostate Cancer Prevention Behavior in Iraqi Male University Staff

Brief summary (registry, in English)

Research Objectives To compare the effectiveness of the education modules on the knowledge, attitude, and practice of male university staffs towards prostate cancer prevention behaviors by comparing the pre- and post-test of Iraqi male university staffs' knowledge, attitude, and practice. Study population The research will proceed to be performed in the country of Iraq. Participants in the research will be male university staff members who are employed at Middle Technical University (MTU). This university contains 17 colleges and institutes, divided into five colleges and twelve institutes that are spread across four cities in Iraq. Inclusion criteria 1. Males at risk are 40 years of age and over. 2. The male who educational level primary school and above. 3. The male who gives informed consent and is willing to participate in the study. 4. Men who did not receive any health education program about prostate cancer. Exclusion criteria 1. The male staff outside middle technical university. 2. The male who has prostate cancer. 3. The male who is critically illness. 4. Withdrawal criteria include males who are unable or unwilling to comply with the study requirements, failure to attend the meeting schedules, and have substantial changes in health conditions, such as developing new medical conditions, having serious adverse events, or any other conditions that could impact the study results. Study Design The study will be a Cluster Randomized Controlled Trial (Cluster RCT) study design among male university staff with a pre-test and post-test to evaluate the effectiveness of the intervention modules that will be used for the study in this phase. A control group will be chosen that has similar characteristics and functioning as the intervention group. Sampling method The study will consist of selecting one college or institute out of 8 using a simple random sampling method, which will involve the classification of one college or institute for the intervention group and one for the control group. This will be done by utilizing a randomization process. The participants will be volunteers to participate in the study, and then the final selection of study participants will be determined by the specific inclusion criteria established for each group. The selection of participants will be contingent upon adherence to the predetermined sample size.

What you commit to

• Study type: Interventional
• Planned participants: 160
• From 20 Sept 2026 to the primary completion date, 20 Dec 2026
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 40 years to - · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.